Surf Therapeutics
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A neuroscience-focused biotech developing next-generation RNA therapeutics and delivery platforms for brain disorders.
Neuroscience
Technology Platform
A proprietary platform combining RNA-targeting modalities with advanced delivery technologies designed to cross the blood-brain barrier and reach specific neuronal targets.
Opportunities
Successfully solving the brain delivery challenge for RNA therapies would unlock a vast pipeline of previously undruggable neurological targets.
Risk Factors
The primary risk is the high technical failure rate associated with novel blood-brain barrier delivery technologies and the complexity of neurological disease biology.
Competitive Landscape
Operates in a highly competitive and technically challenging space with numerous companies pursuing RNA delivery to the CNS.